Pay in 4 interest-free payments of $6.67 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
Similar content being viewed by others Subjects Introduction During the past decade, peptide therapeutics have gained considerable attention in pharmaceutical research and development (R&D) 1,2,3,4
The enhancement of active endogenous GLP-1 leads to increased insulin but reduced glucagon secretion, in addition to delaying gastric emptying and supressing appetite ( Pathophysiology of T2D is characterized by predominant insulin resistance than impaired insulin secretion in Caucasians whereas impaired insulin secretion rather than insulin resistance predominates in Asians ( It is apparent that the therapeutic effects of DPP-IV inhibitors in Asians are more pronounced compared with Caucasians
Maintains cellular energy balance by regulating acetyl-CoA levels
The Current Global Squeeze (The Profitless Boom) Under the current patent monopoly, originator companies hold all the pricing power
US$ 25.28
US$ 20.50
US$ 26.51
US$ 23.18
US$ 28.78
US$ 28.75
US$ 27.07
